全球偏盲市场

预计到 2030 年全球偏盲市场规模将达到 5.032 亿美元

2024年全球偏盲市场规模估计为3.752亿美元，预计到2030年将达到5.032亿美元，在2024-2030年的分析期间内，复合年增长率为5.0%。同侧偏盲是本报告分析的细分市场之一，预计其复合年增长率为4.4%，到分析期结束时市场规模将达到3.076亿美元。象限角膜细分市场在分析期间内的复合年增长率估计为5.7%。

美国市场规模估计为 1.022 亿美元，中国市场预计复合年增长率为 7.8%

预计到2024年，美国半盲市场规模将达到1.022亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到9,910万美元，2024年至2030年的复合年增长率为7.8%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为2.5%和5.0%。在欧洲，预计德国市场的复合年增长率为3.2%。

全球偏盲治疗市场—主要趋势与驱动因素摘要

提高对神经学的理解是否能改善对偏视的治疗？

偏盲症是一种以单眼或双眼失去一半视野为特征的疾病，长期以来一直是一种颇具挑战性的疾病，尤其由于中风、脑损伤或肿瘤引起的神经病变而导致。然而，神经科学和临床影像学的进步如今使人们对该疾病有了更有针对性和更细緻的了解，为改进治疗策略铺平了道路。过去，偏盲被认为是皮质损伤的不可逆后果，治疗方案有限。然而，功能性磁振造影、扩散张量造影和神经眼图的出现，使临床医生能够以前所未有的精确度精确定位视觉通路损伤的精确位置和程度。这种解剖学洞察力的提升，使得我们能够根据每位患者独特的神经病变和视野缺损情况，制定个人化的復健方案。此外，对神经可塑性（大脑自我重组的能力）的更全面理解，也促成了创新治疗方法的发展，旨在透过刺激大脑未受损区域来弥补视野缺损。这些治疗方法包括视觉恢復训练、补偿扫描策略以及旨在调动视觉和注意力迴路的认知感知练习。职能治疗与神经视觉復健的整合也有助于患者更有效地适应视力障碍。临床方案日益趋向多学科化，涉及神经科、眼科医生、验光师、物理治疗师，甚至心理学家，所有这些都有助于实现整体復健。这种日益增长的神经学洞察力不仅提高了诊断的清晰度，也重新定义了偏盲治疗和功能復健的可能性。

辅助科技和视觉辅助工具是否改变了患者的日常生活？

创新辅助科技正迅速改变偏盲治疗的格局，为患者提供实用工具，使其能够更独立、更安全地进行日常活动。其中最具影响力的进展之一是专用视野扩展装置（例如棱镜）的开发。事实证明，正确佩戴这些装置并结合训练，可以显着提高患者的阅读、行走和避障能力。配备扩增实境(AR) 和人工智慧 (AI) 演算法的可穿戴耳机已被开发出来，用于检测并提醒患者盲区内的危险。追踪眼球运动并提供基于回馈的训练的智慧型手机应用程式正在帮助患者重新训练视觉扫描行为，尤其是在驾驶和在拥挤的环境中导航等复杂任务中。萤幕阅读器增强功能、高对比度显示设定和自适应照明正在进一步支援偏盲患者在专业和学术环境中的学习。基于虚拟实境 (VR) 的復健也是一个前景看好的领域，身临其境型训练模组可以模拟真实场景，并在安全可控的环境中鼓励患者补偿策略。除了硬体之外，一些治疗方案也正在涌现，这些方案结合了基于软体的视觉刺激再训练练习，以增强残余视力并改善注意力分配。公立和私立医疗机构正在加大对这些技术的投入，以改善患者的治疗效果，部分此类设备的保险报销范围也逐渐扩大。光学、软体和神经復健的融合，正在将曾经的静态残疾转变为可控的、具有真正适应性功能的疾病。

中风復健是否会影响偏盲照护模式的方向？

鑑于中风是导致偏盲的主要原因，中风治疗和復健通讯协定的演变对视野缺损的治疗和管理产生了直接而显着的影响。随着中风后照护模式越来越多地采用以患者为中心的整合框架，偏盲问题比以往得到更早、更有系统的治疗。快速中风应对系统和急性护理路径现已将视野评估纳入标准评估，从而能够快速诊断和早期疗育偏盲。这种早期发现至关重要，因为视觉復健在亚急性恢復期（通常在中风后几週内）开始效果最佳。跨学科復健团队越来越多地合作，结合物理治疗、职业治疗和视觉治疗，帮助患者重新学习关键技能，例如活动能力、阅读和空间导航。此外，中风后神经回復研究鼓励使用重复性的、有针对性的训练来增强神经可塑性，这对于功能性代偿至关重要。如今，復健中心已融入模拟训练和自适应设备，模拟真实生活环境，例如厨房、街道和办公室，教导患者如何在视力受损的情况下安全独立地生活。以预防和復健为重点的公共卫生工作也透过资助包含视力恢復训练的计画间接惠及病患。家庭参与和患者教育已成为復健的重要组成部分，帮助患者更有效地认识和适应视力丧失。最终，将偏盲纳入更广泛的中风復健框架，可以提高人们对偏盲的认识，改善护理质量，并改善全球患者的长期预后。

推动偏盲治疗市场成长与创新的关键因素是什么？

偏盲治疗市场的成长受到多种因素的驱动，这些因素源于技术进步、神经系统疾病的增加、人口老化以及患者期望的不断变化。全球中风、创伤性脑损伤和脑肿瘤盛行率的上升，使得接受偏盲治疗的患者群体不断扩大，尤其是在北美、欧洲和亚太部分地区。先进影像技术的进步以及诊断影像技术的快速发展，促进了偏盲的早期准确检测，并鼓励患者及时转诊至专科復健机构。技术创新是关键的成长引擎，棱镜光学、扩增实境/虚拟实境系统和视觉训练软体的不断进步，为市场带来了改善生活品质和拓展治疗方案的新产品。医疗保健系统越来越认识到视野缺损对功能的影响，推动视力復健融入神经内科、中风和职业治疗计画。此外，对神经復健研究的投入增加正在发现恢復或补偿视力障碍的新方法，例如脑机介面系统和经颅磁刺激 (TMS)。消费者行为也在不断发展。现今的患者更加积极主动，具有数位意识，并致力于寻找能够让他们独立生活和社会参与的解决方案。远端医疗和虚拟护理平台的发展使视力治疗更容易获得，特别是在服务不足和农村地区。此外，政府和非政府组织正在资助针对视觉障碍者的宣传宣传活动和辅助技术的分发，进一步刺激了市场核准。最后，扩大保险覆盖范围和监管部门对新辅助器具的批准正在降低财务障碍，鼓励患者和医疗保健提供者采用这些创新。这些驱动力正在加速这个曾经被认为是小众市场的扩张，使其成为一个充满活力、多方面的领域，同时具有医疗和技术发展势头。

部分

类型（同侧偏盲、象限偏盲、双颞侧偏盲）；治疗（视力恢復、视野扩展辅助）；最终使用者（医院最终使用者、专科诊所最终使用者）

受访公司范例

• AbbVie Inc.
• Aerie Pharmaceuticals Inc.
• Bioness, Inc.
• Carl Zeiss Meditec AG
• Chadwick Optical
• EssilorLuxottica
• EyeTech Digital Systems
• F. Hoffmann-La Roche Ltd.
• Haag-Streit Holding
• Healio
• Heidelberg Engineering
• Linari Medical
• NeuroVision Imaging LLC
• Novartis AG
• RetroSense Therapeutics, LLC
• Second Sight Medical Products, Inc.
• Sight Sciences
• VisionCare, Inc.
• Vivid Vision
• Vycor Medical Inc.

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Hemianopsia Market to Reach US$503.2 Million by 2030

The global market for Hemianopsia estimated at US$375.2 Million in the year 2024, is expected to reach US$503.2 Million by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Homonymous Hemianopsia, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$307.6 Million by the end of the analysis period. Growth in the Quadrantanopsia segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$102.2 Million While China is Forecast to Grow at 7.8% CAGR

The Hemianopsia market in the U.S. is estimated at US$102.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$99.1 Million by the year 2030 trailing a CAGR of 7.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Hemianopsia Treatment Market - Key Trends & Drivers Summarized

Is Greater Neurological Understanding Leading to Better Hemianopsia Management?

Hemianopsia, a condition characterized by the loss of vision in half of the visual field of one or both eyes, has long been a challenging consequence of neurological damage, especially from strokes, brain injuries, and tumors. However, advances in neuroscience and clinical imaging are now driving a more targeted and nuanced understanding of the condition, paving the way for improved management strategies. Historically, hemianopsia was considered a largely irreversible outcome of cortical damage, with few therapeutic options. But with the advent of functional MRI, diffusion tensor imaging, and neuro-ophthalmological mapping, clinicians can now pinpoint the exact location and extent of visual pathway disruptions with unprecedented accuracy. This improved anatomical insight has enabled the development of individualized rehabilitation programs that are tailored to the patient’s specific neural deficits and visual field loss. Additionally, a more comprehensive understanding of neuroplasticity-the brain's ability to reorganize itself-has led to innovative therapies aimed at stimulating undamaged areas of the brain to compensate for visual field deficits. These therapies include visual restoration training, compensatory scanning strategies, and cognitive-perceptual exercises designed to engage both visual and attentional circuits. Integration of occupational therapy with neuro-visual rehabilitation is also helping patients adapt more effectively to their vision loss. Clinical protocols are increasingly multidisciplinary, involving neurologists, ophthalmologists, optometrists, physiotherapists, and even psychologists, all of whom contribute to holistic recovery. This growing body of neurological insight is not only improving diagnostic clarity but also redefining what is possible in hemianopsia treatment and functional recovery.

Are Assistive Technologies and Visual Aids Transforming Daily Life for Patients?

Innovative assistive technologies are rapidly altering the landscape of hemianopsia treatment by providing patients with practical tools to navigate daily life more independently and safely. One of the most impactful advancements has been the development of specialized visual field expanders, such as prism lenses, which shift images from the blind side into the seeing side of the visual field, thereby increasing environmental awareness. These devices, when fitted correctly and combined with training, have shown significant improvements in patients’ ability to read, walk, and avoid obstacles. Digital solutions are also making an impact-wearable headsets equipped with augmented reality (AR) and artificial intelligence (AI) algorithms are being developed to detect and alert users to hazards in their blind fields. Smartphone applications that track eye movement and offer feedback-based training are helping patients to retrain their visual scanning behaviors, especially during complex tasks like driving or navigating busy environments. Screen reader enhancements, high-contrast display settings, and adaptive lighting are further supporting those with hemianopsia in occupational and academic settings. Virtual reality (VR)-based rehabilitation is another promising field, with immersive training modules that simulate real-world scenarios and encourage compensatory strategies in a safe, controlled environment. Beyond the hardware, therapy programs are also incorporating software-based visual stimuli retraining exercises to strengthen residual visual fields and improve attention allocation. Public and private health institutions are increasingly investing in these technologies to improve patient outcomes, and insurance reimbursement for some of these devices is gradually expanding. The convergence of optics, software, and neuro-rehabilitation is turning what was once a static disability into a manageable condition with real possibilities for adaptive functionality.

Is Stroke Recovery Influencing the Direction of Hemianopsia Care Models?

Given that strokes are the leading cause of hemianopsia, the evolution of stroke care and rehabilitation protocols is having a direct and significant impact on the treatment and management of visual field loss. As post-stroke care models increasingly adopt integrated and patient-centered frameworks, hemianopsia is being addressed earlier and more systematically than ever before. Rapid stroke response systems and acute care pathways now include visual field assessments as part of their standard evaluations, enabling quicker diagnosis of hemianopsia and earlier intervention. This early detection is vital, as visual rehabilitation is most effective when begun during the subacute recovery phase-typically within weeks after the stroke. Multidisciplinary rehabilitation teams are working more cohesively, combining physical therapy, occupational therapy, and vision therapy to help patients relearn essential skills such as mobility, reading, and spatial navigation. Additionally, research into post-stroke neural recovery has prompted the use of repetitive, goal-directed exercises that enhance neuroplasticity, which is critical for functional compensation in hemianopsia. Rehabilitation facilities are now incorporating simulation-based training and adaptive equipment that mimic real-life environments, such as kitchens, roads, and offices, to teach patients how to live safely and independently with visual field deficits. Public health initiatives focused on stroke prevention and recovery are also indirectly benefiting hemianopsia patients by funding programs that include vision restoration training. Family involvement and patient education have become vital components of recovery, helping patients recognize and adapt to their vision loss more effectively. Ultimately, the incorporation of hemianopsia into the broader framework of stroke recovery is elevating its visibility, enhancing care quality, and improving long-term outcomes for patients worldwide.

What Key Factors Are Driving Growth and Innovation in the Hemianopsia Treatment Market?

The growth in the hemianopsia treatment market is driven by several factors rooted in technological advancement, increasing neurological disorders, aging populations, and evolving patient expectations. A rising global incidence of strokes, traumatic brain injuries, and brain tumors is expanding the patient base for hemianopsia treatment-particularly in aging populations across North America, Europe, and parts of Asia-Pacific. The parallel development of advanced diagnostic imaging technologies has made it easier to detect hemianopsia early and accurately, prompting timely referrals to specialized rehabilitation services. Technological innovation is a major growth engine, with continual advances in prism optics, AR/VR systems, and vision-training software introducing new products to market that improve quality of life and expand therapeutic options. Healthcare systems are increasingly recognizing the functional impact of visual field loss, leading to greater integration of vision rehabilitation into neurology, stroke, and occupational therapy programs. Moreover, increasing investments in neuro-rehabilitation research are uncovering novel approaches for restoring or compensating for visual deficits, such as brain-computer interface systems and transcranial magnetic stimulation (TMS). Consumer behavior is also evolving; patients today are more proactive, digitally aware, and invested in finding solutions that allow for independence and social participation. The growth of telemedicine and virtual care platforms has made vision therapy more accessible, especially in underserved or rural areas. Additionally, governments and NGOs are funding awareness campaigns and assistive technology distribution for individuals with vision impairments, boosting market adoption. Lastly, expanding insurance coverage and regulatory approvals for novel assistive devices are lowering financial barriers, encouraging both patients and providers to adopt these innovations. Together, these drivers are accelerating the expansion of a market once considered niche into a dynamic, multidisciplinary sector with substantial medical and technological momentum.

SCOPE OF STUDY:

The report analyzes the Hemianopsia market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Homonymous Hemianopsia, Quadrantanopsia, Bitemporal Hemianopsia); Treatment (Vision Restoration Therapy Treatment, Visual Field Expander Aid Treatment); End-Use (Hospitals End-Use, Specialty Clinics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 37 Featured) -

• AbbVie Inc.
• Aerie Pharmaceuticals Inc.
• Bioness, Inc.
• Carl Zeiss Meditec AG
• Chadwick Optical
• EssilorLuxottica
• EyeTech Digital Systems
• F. Hoffmann-La Roche Ltd.
• Haag-Streit Holding
• Healio
• Heidelberg Engineering
• Linari Medical
• NeuroVision Imaging LLC
• Novartis AG
• RetroSense Therapeutics, LLC
• Second Sight Medical Products, Inc.
• Sight Sciences
• VisionCare, Inc.
• Vivid Vision
• Vycor Medical Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Hemianopsia - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Stroke and Traumatic Brain Injury Rates Throw the Spotlight on Hemianopsia Diagnosis and Treatment
  • Increased Focus on Neuro-Ophthalmology Care Propels Growth in Specialized Therapeutic Solutions
  • Expanding Awareness Among Neurologists and Optometrists Strengthens Business Case for Early Detection
  • Technological Advances in Visual Field Testing Drive Adoption of Accurate Diagnostic Tools
  • Innovation in Vision Restoration Therapies Generates Demand for Neuroplasticity-Based Treatments
  • Growing Use of Visual Aids and Compensatory Devices Expands Addressable Market for Assistive Solutions
  • Integration of Virtual Reality in Rehabilitation Programs Spurs Interest in Digital Therapy Approaches
  • Aging Population Trends Sustain Growth in Post-Stroke Vision Impairment Management
  • Improved Access to Stroke Rehabilitation Centers Drives Adoption of Multidisciplinary Hemianopsia Care
  • Cognitive and Psychological Impacts of Hemianopsia Generate Demand for Holistic Patient Management
  • Increasing Availability of Wearable Vision Technologies Accelerates Demand in Home-Based Care Settings
  • Delays in Diagnosis Due to Low Awareness Pose Challenges to Timely and Effective Treatment
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Hemianopsia Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Hemianopsia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Hemianopsia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Hemianopsia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Homonymous Hemianopsia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Homonymous Hemianopsia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Homonymous Hemianopsia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Quadrantanopsia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Quadrantanopsia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Quadrantanopsia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Bitemporal Hemianopsia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Bitemporal Hemianopsia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Bitemporal Hemianopsia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Vision Restoration Therapy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Vision Restoration Therapy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Vision Restoration Therapy Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Visual Field Expander Aid Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Visual Field Expander Aid Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Visual Field Expander Aid Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 26: USA Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: USA 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 29: USA Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Canada Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: Canada 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• JAPAN
  • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 44: Japan Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Japan Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: Japan 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: Japan 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• CHINA
  • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 53: China Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: China Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: China 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 56: China Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: China 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: China 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• EUROPE
  • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 62: Europe Recent Past, Current & Future Analysis for Hemianopsia by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 63: Europe Historic Review for Hemianopsia by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: Europe 16-Year Perspective for Hemianopsia by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: Europe 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• FRANCE
  • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 74: France Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: France Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: France 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 77: France Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: France 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: France 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• GERMANY
  • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 83: Germany Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Germany Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: Germany 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: Germany 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 92: Italy Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Italy Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: Italy 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: Italy 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 101: UK Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: UK Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: UK 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 104: UK Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: UK 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 110: Spain Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Spain Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: Spain 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: Spain 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: Spain 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 119: Russia Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Russia Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: Russia 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: Russia 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: Russia 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Rest of Europe Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: Rest of Europe 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Hemianopsia by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 138: Asia-Pacific Historic Review for Hemianopsia by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Asia-Pacific 16-Year Perspective for Hemianopsia by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 149: Australia Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Australia Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: Australia 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: Australia 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: Australia 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• INDIA
  • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 158: India Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: India Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: India 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 161: India Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: India 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: India 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 167: South Korea Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: South Korea Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: South Korea 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: South Korea 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: South Korea 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Asia-Pacific Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: Rest of Asia-Pacific 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 185: Latin America Recent Past, Current & Future Analysis for Hemianopsia by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 186: Latin America Historic Review for Hemianopsia by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: Latin America 16-Year Perspective for Hemianopsia by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: Latin America 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Latin America 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 197: Argentina Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Argentina Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Argentina 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Argentina 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Argentina 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 206: Brazil Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Brazil Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Brazil 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Brazil 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Brazil 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 215: Mexico Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Mexico Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Mexico 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Mexico 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: Mexico 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Rest of Latin America Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: Rest of Latin America 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 233: Middle East Recent Past, Current & Future Analysis for Hemianopsia by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 234: Middle East Historic Review for Hemianopsia by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: Middle East 16-Year Perspective for Hemianopsia by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: Middle East 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: Middle East 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 245: Iran Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Iran Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: Iran 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: Iran 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: Iran 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 254: Israel Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Israel Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Israel 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Israel 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Israel 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Saudi Arabia Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Saudi Arabia 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 272: UAE Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: UAE Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: UAE 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: UAE 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: UAE 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Rest of Middle East Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: Rest of Middle East 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• AFRICA
  • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 290: Africa Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Africa Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: Africa 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: Africa 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Africa 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION